1981 - 1990 of 4301 Drugs
Elucirem (gadopiclenol injection)
Elucirem (gadopiclenol) is a gadolinium-based contrast agent indicated in adult and pediatric patients aged 2 years and older for use with magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal vascularity in the central nervous system (brain, spine, and associated tissues) and the body (head and neck, thorax, abdomen, pelvis, and musculoskeletal system).
EluRyng (etonogestrel and ethinyl estradiol vaginal ring)
EluRyng (etonogestrel and ethinyl estradiol ring) is an estrogen/progestin combination hormonal contraceptive (CHC) indicated for use by women to prevent pregnancy. EluRyng is available as a generic.
Viberzi (eluxadoline tablets)
Viberzi (eluxadoline) is a mu-opioid receptor agonist used in adults to treat irritable bowel syndrome with diarrhea (IBS-D).
Vitekta (elvitegravir tablets)
Vitekta (elvitegravir) is a human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor used in combination with an HIV protease inhibitor coadministered with ritonavir and with other antiretroviral drug(s) indicated for the treatment of HIV-1 infection in antiretroviral treatment-experienced adults.
Genvoya (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide tablets)
Genvoya (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) is a four-drug combination of an HIV-1 integrase strand transfer inhibitor (INSTI), a CYP3A inhibitor, and two HIV-1 nucleoside analog reverse transcriptase inhibitors (NRTIs) and is indicated as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are virologically-suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen for at least 6 months with no history of treatment failure and no known substitutions associated with resistance to the individual components of Genvoya.
Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir df)
Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) contains a combination of an HIV-1 integrase strand transfer inhibitor, a mechanism-based inhibitor of cytochrome P450 (CYP) enzymes of the CYP3A family, a synthetic nucleoside analog of cytidine, and an acyclic nucleoside phosphonate (nucleotide) analog of adenosine 5'-monophosphate used to treat HIV-1 in adults who have never taken HIV-1 medications before.
Elzonris (tagraxofusp-erzs injection)
Elzonris (tagraxofusp-erzs) is a CD123-directed cytotoxin for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and in pediatric patients 2 years and older.
Emadine (emedastine difumarate ophthalmic solution)
Emadine (emedastine difumarate) is an anti-allergic medication used to treat symptoms of allergic conditions of the eye such as itching.
Gamifant (emapalumab-lzsg injection)
Gamifant (emapalumab-lzsg) is an interferon gamma (IFN?) blocking antibody indicated for the treatment of adult and pediatric (newborn and older) patients with primary hemophagocytic lymphohistiocytosis (HLH) with refractory, recurrent or progressive disease or intolerance with conventional HLH therapy.
Embeda (morphine sulfate and naltrexone hydrochloride)
Embeda (morphine sulfate and naltrexone hydrochloride) is a combination of a narcotic pain reliever and a special narcotic drug that blocks the effects of other narcotic medicines and alcohol, used to treat moderate to severe pain when around-the-clock pain relief is needed for a long time period.